EI
SBBP

Ellevest Inc’s Strongbridge Biopharma plc. SBBP Stock Holding History

Ellevest Inc’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-332
Closed -$1K – 1429
2020
Q1 		$1K Sell
332
-21
-6% -$55 ﹤0.01% 1044
2019
Q4 		$1K Buy
+353
New +$677 ﹤0.01% 930

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ellevest Inc's SBBP Position: Q2 2020 in Review

Ellevest Inc sold out of Strongbridge Biopharma plc. (SBBP) in Q2 2020, closing a stake of 332 shares — an estimated $1K sold.

Ellevest Inc first reported a position in SBBP in Q4 2019 and held it in 2 quarters. The position peaked at $1K in Q1 2020. 69 funds tracked by Wall St. Rank hold SBBP as of Q2 2020.

  • Ellevest Inc reported no remaining Strongbridge Biopharma plc. position as of Q2 2020 after selling out during the quarter.
  • Ellevest Inc sold 332 Strongbridge Biopharma plc. shares in Q2 2020, an estimated $1K.
  • Ellevest Inc first reported a position in Strongbridge Biopharma plc. in Q4 2019 and held it in 2 quarters.
  • Ellevest Inc's Strongbridge Biopharma plc. position peaked at $1K in Q1 2020.
  • 69 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q2 2020.

Based on Ellevest Inc's 13F filing for Q2 2020, filed 6 Jul 2020.